Search Results
Antithrombotic Therapy for Long-Term Secondary Prevention...Clinical Challenges
Antithrombotics and Stroke
Considerations for Long-Term Antithrombotic Management – A Practical Approach, Dr. Dominick Angiolil
Novel Antithrombotics and Antiplatelets in the Treatment of PAD
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI-EuroPCR 2022
Current Evidence: Antithrombotic Therapy for AF with CAD
Advances in Antithrombotic Therapy - MGR HHS
Antithrombotic Therapy Update: 2 vs. 1 Post-PCI, and 3 vs. 2 Post-PCI & Afib - Dr. Roxana Mehran
Genotype Directed Antiplatelet Therapy, Is the Time Right?
CCC 2019: OPTIMIZING ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION - EXPERTS ON THE CASE
ESO guideline on lacunar ischemic stroke